HC Wainwright & Co. Reiterates Neutral on Kezar Life Sciences

Benzinga · 10/18 11:09
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Kezar Life Sciences (NASDAQ:KZR) with a Neutral.